Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients
To access this article, please choose from the options below
PII: S0041-1345(03)00008-3
doi:10.1016/S0041-1345(03)00008-3
© 2003 Elsevier Science Inc. All rights reserved.
